Darzalex faspro 1,800MG-30,000 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1XW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,258
Award facts
- Contract value 100% obligated
- $65,257.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $65,257.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. This non-set-aside, competitively awarded delivery order has an ultimate completion date of January 29, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement requirements through open competition with the Defense Logistics Agency and serves critical vendor roles for military and veteran healthcare systems. The DLA Medical Supply Chain relies on AmerisourceBergen's extensive portfolio to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for DARZALEX FASPRO, a multiple myeloma treatment, exemplifies the company's capability to deliver specialty oncology medications and other essential pharmaceuticals to support military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FM1XW?
SPE2DR26FM1XW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FM1XW worth?
The government has obligated $65,258 on SPE2DR26FM1XW.
Is contract SPE2DR26FM1XW an order under another contract?
Yes. SPE2DR26FM1XW is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1XW competed?
The extent of competition for SPE2DR26FM1XW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award